Bacterial sepsis of newborn

P16_BACTERIAL_SEPSIS_NEWBO

bacteriemia: An infectious disease caused by bacteria causing sepsis.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — P36 Cause of death: ICD-10 — P36 2 out of 7 registries used, show all original rules.	215
4. Check minimum number of events None	215
5. Include endpoints None	215
6. Filter based on genotype QC (FinnGen only)	205

Control definitions (FinnGen only)

Control exclude: P16_INFECTIONS_SPECIFIC_PERINA_PERIOD

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: P3
Name in latin: Sepsis bacterialis neonatorum

NAME	P16_BACTERIAL_SEPSIS_NEWBO
CONTROL_EXCLUDE	P16_INFECTIONS_SPECIFIC_PERINA_PERIOD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	P36
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	P36
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Bacterial sepsis of newborn based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	26986	11234	15752
Only index persons	10206	4214	5992
Unadjusted period prevalence (%)
Whole population	0.39	0.32	0.44
Only index persons	0.20	0.15	0.23
Median age at first event (years)
Whole population	-	0.00	0.00
Only index persons	0.00	0.00	0.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	205	118	87
Unadjusted period prevalence (%)	0.04	0.04	0.04
Median age at first event (years)	0.00	0.00	0.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
215: Matched controls
2148

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

P36.90

ICD-10 Finland

Suspected bacterial sepsis of newborn

+∞

183.6

149

Z87.6

ICD-10 Finland

Personal history of certain conditions arising in the perinatal period

7.3

29.9

P36.0

ICD-10 Finland

Sepsis of newborn due to streptococcus, group B

+∞

24.4

P36.99

ICD-10 Finland

Bacterial sepsis of newborn, unspecified

+∞

22.3

P07.3

ICD-10 Finland

Other preterm infants

5.8

19.1

P36.3

ICD-10 Finland

Sepsis of newborn due to other and unspecified staphylococci

+∞

12.6

P22.0

ICD-10 Finland

Respiratory distress syndrome of newborn

15.6

12.5

P22.1

ICD-10 Finland

Transient tachypnoea of newborn

5.9

10.6

P39.9

ICD-10 Finland

Infection specific to the perinatal period, unspecified

+∞

7.3

602

Kela drug reimbursment

Children's severe malnutrition

3.7

6.9

P01.10

ICD-10 Finland

Fetus and newborn affected by premature rupture of membranes 1-7 days before delivery

11.5

6.9

AA5HE

NOMESCO Finland

Brain ultrasound examination in a child

3.2

6.6

P36.4

ICD-10 Finland

Sepsis of newborn due to Escherichia coli

+∞

6.3

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

6.2

214

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

3.58

4.25

4.0

4.5

27.93

22.33

umol/l

0.88

(3001186) Copper [Moles/volume] in Serum or Plasma

8.76

3.28

1.2

1.0

17.65

21.94

umol/l

—

(3019225) pH of Specimen

2.61

2.76

1.9

3.7

—

(3020891) Body temperature

3.25

2.68

3.7

6.9

—

(3023368) Bacteria identified in Blood by Culture

291

1.74

2.62

5.9

4.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

4.48

2.49

1.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.31

2.44

6.7

11.4

0.65

0.64

0.01

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.10

2.41

1.2

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.10

2.41

1.2

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

357

1.64

2.39

4.0

4.3

4.48

2.62

e6/l

0.30

213

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

4.71

2.28

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

467

1.56

2.23

3.5

3.6

2.69

2.62

mg/l

0.11

415

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

351

1.59

2.10

4.1

4.2

0.75

0.72

e6/l

0.03

206

(3002256) Pathology report gross observation

106

1.98

1.0

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

404

1.52

1.86

3.4

5.2

8.09

8.46

mmol/l

0.17

385

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

3.11

1.81

1.0

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

407

1.51

1.80

3.8

3.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

214

1.64

1.72

3.4

5.0

7.76

8.65

g/l

0.57

205

(3015736) pH of Urine

575

1.44

1.69

3.7

3.4

6.27

6.29

0.02

(3020717) Zinc [Moles/volume] in Serum or Plasma

2.64

1.67

1.6

2.4

12.10

12.09

umol/l

—

(4034850) Laboratory test

3.21

1.67

8.5

5.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

137

1.76

1.62

3.3

4.4

0.81

12.60

mg/mmol

1.94

115

(3012516) Albumin [Mass/volume] in Urine

138

1.74

1.59

2.9

3.8

40.06

130.31

mg/l

1.08

117

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

1.54

0.0

3.6

—

3.43

—

(3004588) Protein electrophoresis panel - Serum or Plasma

3.38

1.53

1.2

3.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

3.38

1.53

1.4

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

189

1.62

1.49

2.8

2.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

541

1.40

1.47

8.1

9.4

25.20

26.48

umol/l

0.08

494

(3021960) Folate [Moles/volume] in Serum or Plasma

198

1.60

1.47

1.6

1.3

18.52

18.78

nmol/l

0.04

171

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

191

1.60

1.43

2.6

2.2

—

(3000494) Fungus identified in Specimen by Culture

135

1.70

1.42

1.7

2.3

—

(40761535) Cells panel - Urine sediment

2.00

1.41

4.2

3.7

—

(40768446) Kidney Pathology biopsy report

2.46

1.40

2.6

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

2.46

1.40

5.1

8.4

2.33

1.61

mg/l

—

(4035726) Immunohistochemistry procedure

1.89

1.39

2.1

1.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

2.98

1.36

1.0

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.87

1.35

2.5

2.3

—

(3000991) Gas panel - Venous blood

412

1.41

1.34

9.7

11.8

—

(3023520) Reticulocytes [#/volume] in Blood

187

1.57

1.32

5.1

4.9

64.26

60.97

e9/l

0.18

115

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.94

1.31

3.1

5.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

230

1.51

1.29

2.9

2.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.82

1.26

2.0

—

(3022313) Gas panel - Capillary blood

400

1.39

1.23

11.2

10.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

109

1.71

1.23

2.8

2.2

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.67

1.22

1.6

2.4

0.91

1.11

umol/l

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.86

1.17

2.7

2.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.86

1.17

2.7

2.4

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

2.09

1.16

1.6

1.3

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.53

1.15

9.6

7.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.53

1.15

1.0

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

676

1.32

1.13

3.8

3.7

0.00

estimate

—

113

(3002032) Base excess in Venous blood by calculation

452

1.35

1.12

9.7

10.2

-0.23

1.11

mmol/l

1.04

343

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

611

1.32

1.11

5.2

5.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

362

1.38

1.10

4.6

3.5

—

(21494434) Karyotype in Bone marrow

2.41

1.09

1.4

—

(40768441) Liver Pathology biopsy report

2.41

1.09

2.0

2.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

2.22

1.09

2.3

2.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

2.22

1.09

1.1

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

2.04

1.06

2.6

6.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

2.30

1.04

1.2

1.0

—

(3030467) Casts [#/volume] in Urine by Automated count

541

1.32

1.03

5.3

4.8

0.19

0.29

e6/l

0.46

409

(3009261) Glucose [Presence] in Urine by Test strip

683

1.30

1.03

3.7

0.00

estimate

—

117

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.93

1.03

2.5

1.8

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

104

909

1.28

0.99

7.2

5.4

140.60

135.17

u/l

0.22

858

(40761511) CBC panel - Blood by Automated count

178

1669

1.38

0.99

11.7

8.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

405

1.34

0.99

3.3

2.7

2.41

mmol/l

0.06

371

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

1.78

0.98

2.8

2.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

1.78

0.98

2.8

2.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

1.89

0.98

2.7

6.3

93.60

97.65

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.98

0.0

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

0.00

0.96

0.0

2.5

—

26.20

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.96

0.0

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

680

1.28

0.95

6.2

5.2

0.00

estimate

—

118

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.25

0.94

8.0

11.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

455

1.31

0.93

14.2

10.4

1.06

0.93

mmol/l

0.15

322

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1.78

0.91

5.0

6.9

520.64

452.65

mg/l

0.16

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1.78

0.91

1.7

2.3

—

(3009343) pH of Capillary blood

457

1.30

0.90

14.2

10.4

—

7.40

—

(3019150) Specific gravity of Urine by Refractometry

347

1.34

0.90

2.7

3.2

1.02

1.01

kg/l

1.53

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.65

0.89

2.7

2.4

—

(3016879) Cocaine [Presence] in Urine

198

1.41

0.85

1.1

1.9

—

(3019060) Gas panel - Arterial blood

1.96

0.85

9.0

1.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.96

0.85

1.2

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

1.96

0.85

6.7

5.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.96

0.85

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.96

0.85

4.3

6.3

—

(44813793) Dust mix specific IgE antibody measurement

1.96

0.85

1.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

138

1263

1.26

0.84

3.5

3.3

14.22

14.36

pmol/l

0.29

129

1150

(36304419) Bacteria [Presence] in Urine

546

1.27

0.84

5.1

4.8

—

(4200892) Spirometry reversibility

1.59

0.83

1.4

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1.90

0.82

2.8

1.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

186

0.62

0.81

1.3

1.2

—

16.06

—

(40758558) Short blood count panel - Blood

653

1.25

0.81

7.6

10.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.79

0.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.79

0.0

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.84

0.79

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.79

0.0

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.79

0.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.79

0.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.79

0.0

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.78

0.0

1.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

167

1.42

0.77

10.2

9.6

104.78

105.31

mmol/l

0.26

167

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.78

0.77

1.3

1.4

—

(3016038) Potassium [Moles/volume] in Urine

1.78

0.77

4.2

2.1

50.00

38.59

mmol/l

—

(3028300) Cannabinoids [Presence] in Urine

211

1.37

0.76

1.4

1.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.69

0.75

1.9

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.69

0.75

1.3

3.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.11

0.75

2.4

1.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.11

0.75

8.4

6.9

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.11

0.75

8.4

6.8

—

(3002582) Erythrocytes [#/volume] in Urine

582

1.24

0.74

5.2

5.0

26.73

25.08

e6/l

0.03

446

(3024928) Oxygen saturation in Venous blood

1.66

0.74

20.7

11.3

—

(40761536) Microorganisms panel - Urine sediment

110

0.53

0.74

1.7

3.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

158

0.61

0.74

1.1

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

158

0.61

0.74

1.5

1.4

—

(3023410) Appearance of Cerebral spinal fluid

1.63

0.73

6.1

7.3

—

(3000330) Specific gravity of Urine by Test strip

1.63

0.73

4.4

2.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

915

0.81

0.73

2.0

2.1

—

(3045142) Bone marrow Pathology biopsy report

2.02

0.73

1.4

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1.65

0.73

1.4

2.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

423

1.27

0.73

2.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

146

0.60

0.72

1.3

—

(3018095) Leukocytes [#/volume] in Urine

671

1.23

0.71

6.4

5.8

29.81

61.95

e6/l

0.63

460

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.73

0.70

1.4

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

260

1.32

0.69

4.9

6.2

8.80

1.75

mg/l

0.53

189

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.69

0.69

2.9

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.87

0.69

2.4

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1.87

0.69

1.0

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

417

1.26

0.68

4.9

3.8

—

(3044889) 12 lead EKG panel

642

0.81

0.67

2.7

2.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.57

0.67

4.0

2.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

172

1.38

0.67

1.8

2.4

0.99

1.00

g/l

0.03

164

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

400

1.26

0.66

2.4

2.5

—

(3051651) Icteric interference index of Serum or Plasma

1.74

0.64

7.8

5.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

814

0.83

0.64

14.4

6.9

106.90

110.98

ml/min/173m2

0.50

501

(3022217) INR in Platelet poor plasma by Coagulation assay

374

1.26

0.63

7.8

5.7

1.08

1.16

inr

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

105

0.56

0.63

1.5

2.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

125

1154

1.20

0.61

10.9

11.7

3.07

3.32

e9/l

0.77

102

955

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

0.60

0.0

2.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

442

1.23

0.60

2.9

3.5

—

(3000764) Benzodiazepines [Presence] in Urine

211

1.32

0.60

1.3

1.9

—

(3027008) Opiates [Presence] in Urine

211

1.32

0.60

1.3

1.9

—

(3020393) Adenovirus Ag [Presence] in Stool

1.56

0.60

1.3

2.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

898

1.19

0.59

2.9

2.3

5.60

5.33

mmol/l

0.98

806

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.58

0.0

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.50

0.58

1.4

1.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.50

0.58

1.0

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

113

1038

1.18

0.58

9.1

10.4

—

(3001604) Monocytes [#/volume] in Blood

119

1098

1.19

0.57

8.0

10.1

0.56

e9/l

0.10

100

904

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

426

1.22

0.57

9.4

9.7

22.78

23.47

mmol/l

0.91

426

(3044290) Cell count panel - Cerebral spinal fluid

1.52

0.55

6.0

6.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1.49

0.54

1.4

2.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.45

0.53

2.7

4.8

27.00

26.52

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.42

0.52

12.9

14.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

226

1.27

0.51

2.0

1.6

—

(3027944) Amphetamines [Presence] in Urine

209

1.28

0.49

1.3

1.9

—

(3006315) Basophils [#/volume] in Blood

118

1098

1.16

0.49

8.1

10.1

0.04

e9/l

0.06

902

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1.54

0.49

10.0

3.1

663.43

275.99

ug/l

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

1.50

0.48

2.1

4.2

707.71

731.55

e6/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

120

1.36

0.47

1.2

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

129

1.34

0.47

1.4

574.29

56780112.88

pmol/l

0.50

118

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

263

0.78

0.47

2.1

1.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

147

1.32

0.47

2.7

2.0

176.38

174.51

u/ml

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

165

1.30

0.47

1.3

1.9

—

(3011288) Drugs identified in Urine by Screen method

156

1.31

0.47

1.3

2.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.45

0.46

1.6

1.2

—

(3000492) Spirometry study

103

1.38

0.46

1.9

1.4

—

(3019198) Lymphocytes [#/volume] in Blood

120

1123

1.15

0.45

8.0

10.0

2.43

2.35

e9/l

0.27

106

955

(3007853) Bacteria identified in Skin by Aerobe culture

249

1.24

0.44

3.0

1.9

—

(3031040) Bacteria [#/volume] in Urine by Automated count

104

964

1.15

0.44

4.5

3.9

—

76.08

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

324

1.21

0.44

1.9

1.4

97.66

96.65

pmol/l

0.04

165

(3013115) Eosinophils [#/volume] in Blood

119

1114

1.15

0.44

9.5

10.9

0.20

0.22

e9/l

0.68

103

942

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

842

0.87

0.43

1.8

1.9

1.32

3.55

u/ml

1.15

145

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

149

1.30

0.43

2.7

2.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.57

0.42

3.0

1.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

555

1.16

0.42

1.9

2.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.53

0.41

1.0

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.53

0.41

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.41

0.0

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

2.1

—

4.91

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.41

0.0

1.3

—

336.13

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.41

0.0

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

0.41

0.0

2.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

101

0.68

0.40

1.9

2.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

148

1412

1.15

0.40

4.2

3.6

1.96

2.04

mu/l

0.42

142

1322

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.39

0.0

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.39

0.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.38

0.39

1.0

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.38

0.39

1.0

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

1.36

0.38

2.7

4.8

10.11

7.99

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.36

0.38

1.0

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

1.36

0.38

2.7

4.8

69.67

66.34

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1.40

0.38

2.4

4.0

508.80

420.64

umol/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

263

1.21

0.38

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

189

1.24

0.38

6.7

3.7

649.27

1075.23

ng/l

0.51

116

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.32

0.37

1.2

1.3

—

(3006245) CD3-CD19+ cells/100 cells in Blood

1.41

0.37

2.8

4.9

13.20

18.22

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

502

1.15

0.37

16.3

13.7

24.34

24.69

mmol/l

0.44

502

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

184

1788

1.20

0.36

3.8

3.9

—

(3034770) Mitochondria Ab [Titer] in Serum

1.48

0.36

1.2

2.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

1.48

0.36

1.3

2.9

—

54.29

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

176

1706

1.17

0.35

15.4

11.6

23.47

24.24

mg/l

0.12

123

1151

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.36

0.34

1.3

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.36

0.34

1.3

1.5

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1.37

0.33

11.4

14.5

90.35

95.33

—

(3022145) Colonoscopy Study observation

1.37

0.33

1.5

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.28

0.32

2.5

1.7

—

(3019230) Fractional oxyhemoglobin in Venous blood

1.36

0.31

12.7

11.4

73.86

71.37

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

307

1.17

0.31

2.0

1.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.26

0.29

1.0

1.3

—

(3007461) Platelets [#/volume] in Blood

198

1943

1.23

0.29

23.3

16.8

283.14

274.26

e9/l

0.90

190

1843

(3019832) Treponema pallidum Ab [Presence] in Serum

246

0.84

0.28

1.8

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

198

1945

1.22

0.27

23.9

17.3

38.99

39.17

0.26

190

1857

(3025159) Blasts/100 leukocytes in Blood

1.28

0.26

2.6

7.1

0.33

0.00

—

(21494815) CD4 cells/100 lymphocytes in Specimen

1.20

0.26

3.0

4.8

42.90

35.64

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

0.69

0.26

1.2

1.1

—

3.77

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.67

0.26

1.0

1.4

—

(3026361) Erythrocytes [#/volume] in Blood

198

1946

1.21

0.26

23.2

16.7

4.59

e12/l

0.05

190

1837

(3048929) Epstein Barr virus Ab [Presence] in Serum

274

1.15

0.25

2.2

1.8

—

(3010813) Leukocytes [#/volume] in Blood

198

1947

1.20

0.25

23.2

16.7

6.77

6.89

e9/l

0.33

190

1839

(3021879) Hepatitis B virus core Ab [Presence] in Serum

126

0.78

0.25

2.3

1.5

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.19

0.25

12.0

14.2

0.78

0.70

—

(40768797) Stomach Pathology biopsy report

124

1.22

0.24

1.8

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

134

1.21

0.23

2.1

1.9

—

(3014051) Protein [Presence] in Urine by Test strip

1.29

0.23

4.4

1.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

163

1.18

0.22

2.1

2.5

5.81

5.49

u/l

0.10

106

(1761868) Lipid panel - Serum or Plasma

239

1.15

0.22

2.1

2.0

—

(1616796) Gas panel - Central venous blood

1.22

0.22

2.0

6.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.22

0.22

2.4

1.8

—

(3017181) Myelocytes/100 leukocytes in Blood

107

1.23

0.22

3.5

6.8

1.67

0.61

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.21

0.0

1.4

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.21

0.0

2.3

—

3.82

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

5.2

—

360.33

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

302

0.88

0.21

2.0

2.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.21

0.0

5.2

—

4.51

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

1.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(40768804) Tissue Pathology biopsy report

312

0.88

0.21

1.7

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

172

1682

1.11

0.20

22.6

16.4

14.00

13.25

1.58

172

1654

(3023323) Follitropin [Units/volume] in Serum or Plasma

144

0.82

0.20

1.7

2.6

4.41

7.01

iu/l

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1.26

0.20

4.2

2.8

17.08

7.91

ug/l

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.00

0.20

0.0

5.3

—

(3045414) Leukocytes [Presence] in Urine

1.23

0.20

3.8

1.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

185

0.85

0.19

1.2

2.34

2.68

u/ml

0.07

143

(3024980) IgG subclass 4 [Mass/volume] in Serum

1.13

0.19

1.5

1.7

1.09

0.59

g/l

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.21

0.18

2.1

1.6

—

(3003694) ABO and Rh group [Type] in Blood

507

1.09

0.17

1.8

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.18

0.17

2.8

4.8

—

(3042936) Bacteria identified in Isolate by Culture

168

1.14

0.16

5.2

1.9

—

(3025941) Bacteria identified in Stool by Culture

0.77

0.16

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

198

1.12

0.15

4.8

2.6

38.17

38.69

ng/l

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.79

0.15

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

0.78

0.15

1.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

103

1.17

0.14

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

106

0.84

0.13

1.2

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

114

1.15

0.12

2.0

1.6

—

(36660697) Celiac disease serology panel - Serum

357

1.08

0.12

1.3

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1.09

0.09

2.6

4.2

187.66

6.34

u/ml

—

(3035933) Granulocytes/100 leukocytes in Blood

1.07

0.08

1.7

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.81

0.08

2.4

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

185

1.09

0.08

1.2

0.39

0.96

u/ml

0.81

142

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

560

1.05

0.08

5.1

3.5

—

(3052851) Hemolysis interference index of Serum or Plasma

1.05

0.08

6.3

3.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1.03

0.08

1.6

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

186

1.08

0.07

1.2

10.63

7.03

u/ml

0.26

145

(3000850) Epithelial cells [#/volume] in Urine

386

0.95

0.07

4.1

3.8

6.71

8.15

e6/l

0.29

341

(3037467) Urinalysis macro (dipstick) panel - Urine

101

991

1.03

0.06

5.5

4.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

168

1.08

0.06

1.7

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

316

1.05

0.06

2.6

3.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

424

0.96

0.05

2.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

139

1.08

0.05

4.8

2.8

30.30

33.62

u/l

—

108

(3021589) Normoblasts [#/volume] in Blood

106

1045

1.03

0.04

9.2

11.6

0.00

0.01

e9/l

0.47

780

(3013826) Glucose [Moles/volume] in Serum or Plasma

876

1.03

0.04

12.1

7.6

6.61

6.07

mmol/l

1.01

823

(3007164) IgA [Mass/volume] in Serum or Plasma

791

0.98

0.03

1.8

1.32

1.49

g/l

0.72

394

(3013707) Erythrocyte sedimentation rate by Westergren method

108

1068

1.02

0.03

4.3

4.7

9.04

7.35

mm/h

0.60

102

996

(3013512) EKG study

178

0.95

0.02

3.6

2.7

—

(3048689) Calprotectin [Mass/mass] in Stool

391

1.03

0.02

2.0

3.6

42.37

71.63

ug/g

2.38

313

(3029937) Albumin [Presence] in Urine by Test strip

327

0.97

0.01

2.7

3.9

0.00

estimate

—

114

(3026008) Bacteria identified in Urine by Culture

407

0.98

0.01

3.7

2.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

1.07

0.00

1.7

1.9

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

114

1.05

0.00

1.4

1.5

280.58

363.56

mu/l

0.60

109

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

118

1.02

0.00

2.0

2.1

—

14.58

—

(3028707) Methadone [Presence] in Urine by Screen method

111

0.99

0.00

1.3

2.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1.04

0.00

3.4

5.6

1.20

0.36

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

198

1.01

0.00

1.3

2.65

4.31

u/ml

0.41

150

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

62.67

—

(3016228) CD19 cells/100 cells in Blood

0.00

-0.00

0.0

4.0

—

13.60

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

-0.00

0.0

1.2

—

(3032641) Amino acids panel - Urine

0.00

-0.00

0.0

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

761.60

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

-0.00

0.0

1.0

—

305.00

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.87

-0.00

1.3

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.91

-0.00

1.2

1.1

—

(3015183) Erythrocyte sedimentation rate

0.00

-0.00

0.0

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

0.00

-0.00

0.0

1.5

—

1.55

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.96

-0.00

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.95

-0.00

1.4

—

(3022621) pH of Urine by Test strip

0.93

-0.00

3.7

1.9

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

-0.00

0.0

2.6

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

-0.00

0.0

11.4

—

47.06

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

10.0

—

2.74

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.1

—

0.47

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

2.8

—

25.00

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

25.77

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

2.2

—

1.33

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.02

-0.00

1.2

1.4

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

26.5

—

25.83

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.87

-0.00

1.0

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

186.03

—

(3000012) Reticulocyte production index

0.00

-0.00

0.0

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.89

-0.00

1.0

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.96

-0.00

1.0

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.00

-0.00

7.8

6.2

1.42

2.12

ug/l

—

(3010503) CD19 cells [#/volume] in Blood

0.00

-0.00

0.0

3.5

—

0.28

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

-0.00

0.0

26.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

(3034426) Prothrombin time (PT)

0.00

-0.00

0.0

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

9.90

—

(21494814) CD8 cells/100 lymphocytes in Specimen

0.00

-0.00

0.0

4.0

—

(40757373) Influenza virus identified in Isolate

0.00

-0.00

0.0

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.6

—

(3012441) Differential panel - Pleural fluid

0.00

-0.00

0.0

1.4

—

(3002619) Bacteria identified in Specimen by Culture

0.00

-0.00

0.0

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

0.95

-0.00

2.0

2.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(40768793) Breast Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3045788) Cell count panel - Pleural fluid

0.00

-0.00

0.0

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.91

-0.00

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.4

—

107.00

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

5.6

—

138.71

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

-0.00

0.0

1.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

1.4

—

33.22

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.96

-0.00

1.0

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.00

-0.00

2.0

2.3

0.17

0.13

nmol/l

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint P16_BACTERIAL_SEPSIS_NEWBO and mortality.

Females

No data

Males

Parameter	HR [95% CI]	p-value
P16_BACTERIAL_SEPSIS_NEWBO	1.309 [1.03, 1.66]	0.027
Birth year	0.988 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 75 out of 15045 males with P16_BACTERIAL_SEPSIS_NEWBO died.

Mortality risk

Mortality risk for people of age

years, who have P16_BACTERIAL_SEPSIS_NEWBO.

N-year risk	Females	Males
1	No data	0.274%
5	No data	1.604%
10	No data	3.955%
15	No data	7.652%
20	No data	12.738%

Relationships between endpoints

↥

Index endpoint: P16_BACTERIAL_SEPSIS_NEWBO – Bacterial sepsis of newborn

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Bacterial sepsis of newborn

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints